Rajiv Patni's Net Worth
-$58.5 Thousand
Who is Rajiv Patni?
Rajiv Patni does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include REATA PHARMACEUTICALS INC, Adamas Pharmaceuticals Inc, PORTOLA PHARMACEUTICALS INC, and Ocera Therapeutics, Inc..
SEC CIK
Rajiv Patni's CIK is 0001616200
Past Insider Trading and Trends
2014 was Rajiv Patni's most active year for acquiring shares with 3 total transactions. Rajiv Patni's most active month to acquire stocks was the month of February. 2020 was Rajiv Patni's most active year for disposing of shares, totalling 2 transactions. Rajiv Patni's most active month to dispose stocks was the month of February. 2016 saw Rajiv Patni paying a total of $102,450.00 for 52,500 shares, this is the most they've acquired in one year. In 2020 Rajiv Patni cashed out on 160,000 shares for a total of $986,250.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REATA PHARMACEUTICALS INC No price found
EVP, Chief R&D Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -45.00K |
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
∞
| 45K |
—
|
—
| 45K |
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adamas Pharmaceuticals Inc No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +156.73% | 30K |
—
|
—
| 49.14K |
Apr 8
| |||
Form 4
| -11.03% | -2.37K |
$8.00 | -$18,992.00 | 19.14K |
Mar 20
| |||
Form 4
| -5.50% | -1.25K |
$25.94 | -$32,476.88 | 21.52K |
Mar 21
| |||
Form 4
| +66.89% | 9.13K |
—
|
—
| 22.77K |
Mar 6
| |||
Form 4
| -5.10% | -733.00 |
$17.04 | -$12,490.32 | 13.64K |
Mar 21
| |||
Form 4
| +91.67% | 6.88K |
—
|
—
| 14.38K |
Jan 18
| |||
Form 4
|
∞
| 7.5K |
$13.66 | $102,450.00 | 7.5K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PORTOLA PHARMACEUTICALS INC No price found
EVP, CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
∞
| 35K |
—
|
—
| 35K |
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ocera Therapeutics, Inc. No price found
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.05K |
$3.97 | $20,048.50 | 5.05K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Quince Therapeutics, Inc. (QNCX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||